3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Venous Thromboembolism
8
Venous Thrombosis
4
Neoplasms
4
Pulmonary Embolism
2
Lung Neoplasms
2
Vascular Diseases
1
Urogenital Neoplasms
1
Thrombosis
1
Thromboembolism
1
Thrombocytopenia
1
Prostatic Neoplasms
1
Myeloproliferative Disorders
1
Multiple Myeloma
1
Lymphoproliferative Disorders
1
Lymphoma
1
Lymphatic Diseases
1
Leukemia
1
Intestinal Neoplasms
1
Hemostatic Disorders
1
Digestive System Neoplasms
1
Colorectal Neoplasms
1
Breast Neoplasms
1
Brain Neoplasms
1
Interventions
apixaban
4
Enoxaparin
3
Rivaroxaban
2
Heparin, Low-Molecular-Weight
2
Dalteparin
2
edoxaban
1
Warfarin
1
Tinzaparin
1
Simvastatin
1
Observation
1
Fondaparinux
1
Data Collection
1
Dabigatran
1
Aspirin
1
Anticoagulants
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Thrombosis
×
Tinzaparin
×
Classical hematology
×
Clear all
NCT01817257
2018-10-29
ALICAT
Cardiff University
Phase 2
Terminated
2 enrolled